Skip Navigation LinksHome > August 2014 - Volume 24 - Issue 4 > Contributor Index

August 2014 - Volume 24 - Issue 4 - Contributor Index

View All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Actions
View
Show
Previous of 7 Next
Author Name Article
Alrwas, Anas

Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Arkenau, Hendrik-Tobias

Resistance surveillance in a BRAF mutant melanoma patient on long-term BRAF-inhibitor treatment

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Asgari, Maryam M.

Comparing characteristics of melanoma cases arising in health maintenance organizations with state and national registries

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Astanehe, Arezoo

Extracutaneous melanoma epidemiology in British Columbia

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Atkinson, Victoria G.

Response rate to vemurafenib in patients with B-RAF-positive melanoma brain metastases: a retrospective review

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Babovic, Nada Lj.

Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Bassett, Roland Jr

Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Battistella, Maxime

BRAFV600 mutation levels predict response to vemurafenib in metastatic melanoma

Purchase Access
PDF
+ Favorites
Request Permissions
Becker, Nils

Mucosal melanoma: correlation of clinicopathologic, prognostic, and molecular features

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Bedikian, Agop Y.

Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Berthod, Gregoire

Accuracy of sentinel lymph node dissection for melanoma staging in the presence of a collision tumour with a lymphoproliferative disease

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Boubaker, Ariane

Accuracy of sentinel lymph node dissection for melanoma staging in the presence of a collision tumour with a lymphoproliferative disease

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Branicki, Wojciech

Increased risk of developing cutaneous malignant melanoma is associated with variation in pigmentation genes and VDR, and may involve epistatic effects

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Brice, Pauline

Four cases of rituximab-associated melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Cain, Suzanne

Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chan, Hee-Lam

In-vitro melanoma models: invasive growth is determined by dermal matrix and basement membrane

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chen, Guilin

Comparative analysis of pathology and boronophenylalanine uptake in experimental orthotopic and heterotopic amelanotic melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chin, Melvin

Resistance surveillance in a BRAF mutant melanoma patient on long-term BRAF-inhibitor treatment

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Colman, Matthew W.

Does metastasectomy improve survival in skeletal melanoma?

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Commandeur, Suzan

In-vitro melanoma models: invasive growth is determined by dermal matrix and basement membrane

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Actions
View
Show
Previous of 7 Next